Quest Diagnostics (DGX) Other Non-Current Liabilities (2009 - 2026)

Quest Diagnostics has disclosed Other Non-Current Liabilities across 18 years of filings, most recently posting $1.1 billion for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities rose 18.99% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (up 18.99% YoY), while the FY2025 annual figure was $957.0 million, up 2.03% from the prior year.
• Other Non-Current Liabilities came in at $1.1 billion for Q2 2026 at Quest Diagnostics, up from $1.0 billion in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.1 billion in Q2 2026 to a low of $6.0 million in Q2 2024.
• Average Other Non-Current Liabilities over 5 years is $788.6 million, with a median of $875.0 million recorded in 2023.
• Year-over-year, Other Non-Current Liabilities sank 93.18% in 2024 and jumped 14733.33% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $812.0 million in 2022, then climbed by 7.88% to $876.0 million in 2023, then increased by 7.08% to $938.0 million in 2024, then gained by 2.03% to $957.0 million in 2025, then climbed by 10.66% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.1 billion in Q2 2026, $1.0 billion in Q1 2026, and $957.0 million in Q4 2025.